Oric Pharmaceuticals

$21.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.62 (-6.99%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ORIC and other stocks, options, and ETFs commission-free!

About ORIC

Oric Pharmaceuticals, Inc. Common Stock, also called Oric Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance.

CEO
Jacob M. Chacko
Employees
61
Headquarters
South San Francisco, California
Founded
2014
Market Cap
760.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
282.67K
High Today
$23.21
Low Today
$21.49
Open Price
$23.21
Volume
334.10K
52 Week High
$40.81
52 Week Low
$18.60

ORIC Earnings

-$4.46
-$2.97
-$1.49
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 19, After Hours

You May Also Like

MANH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure